- FTC and DOJ Announce Additional Workshops on the 2023 Draft Merger Guidelines ( )
- FTC and DOJ to Co-Host 2023 Draft Merger Guidelines Workshop on September 5 ( )
- Biopharmaceutical Giant Amgen to Settle FTC and State Challenges to its Horizon Therapeutics Acquisition ( )
- FTC Secures Settlement with ICE and Black Knight Resolving Antitrust Concerns in Mortgage Technology Deal ( )
- FTC and DOJ Announce Workshops on the 2023 Draft Merger Guidelines ( )
- FTC Acts to Prevent Interlocking Directorate Arrangement, Anticompetitive Information Exchange in EQT, Quantum Energy Deal ( )
- FTC and DOJ Extend Public Comment Period by 30 Days on Proposed Changes to HSR Form ( )
- Statement Regarding Termination of CooperCompanies’ Attempted Acquisition of Cook Medical’s Reproductive Health Business ( )
- FTC and DOJ Seek Comment on Draft Merger Guidelines ( )
- FTC Sues to Block IQVIA’s Acquisition of Propel Media to Prevent Increased Concentration in Health Care Programmatic Advertising ( )
- FTC and DOJ Propose Changes to HSR Form for More Effective, Efficient Merger Review ( )
- FTC Policy Director Issues Statement Commending Maine’s Repeal of Certificate of Public Advantage Law ( )
- FTC Staff Opposes State Legislation in North Carolina Designed to Shield UNC Health System from Antitrust Enforcement ( )
- FTC, DOJ Issue Summary on Joint Pharmaceutical Merger Analysis Workshop ( )
- Statement Regarding the Termination of Boston Scientific Corporation’s Attempted Acquisition of a Majority Stake in M.I. Tech Co., Ltd. ( )
- FTC Sues to Block Biopharmaceutical Giant Amgen from Acquisition That Would Entrench Monopoly Drugs Used to Treat Two Serious Illnesses ( )
- Statement Regarding the Termination of CalPortland Company’s Attempted Acquisition of Assets Owned by Rival Cement Producer Martin Marietta Materials, Inc. ( )
- FTC Sues to Stop the Potentially Illegal Integration of New Orleans Area Hospitals Over Failure to Follow Federal Reporting Law ( )
- FTC Staff Seeks Court Order Preventing ICE from Consummating its Acquisition of Rival Black Knight Pending Agency Administrative Challenge ( )
- FTC, Justice Department, and European Commission Hold Third U.S.- EU Joint Technology Competition Policy Dialogue ( )
- FTC Files Amicus Brief in Sage Chemical vs. Supernus Pharmaceutical Supporting Competition in the Market for Drug Used to Treat Advanced Parkinson’s Disease ( )
- FTC and Justice Department to Hold Annual Spring Enforcers Summit ( )
- FTC Acts to Block Deal Combining the Two Top Mortgage Loan Technology Providers ( )
- Statement of Elizabeth Wilkins, Director of the FTC’s Office of Policy Planning, on the Decision of SUNY Upstate Medical University and Crouse Health System, Inc. to Drop Their Proposed Merger ( )
- FTC, DOJ Issue Fiscal Year 2021 Hart Scott Rodino Premerger Notification Report ( )
- FTC Announces 2023 Update of Size of Transaction Thresholds for Premerger Notification Filings and Interlocking Directorates ( )
- FTC Approves Final Order Preserving Farm Store Competition in the Midwest and the South ( )
- FTC Seeks to Block Microsoft Corp.’s Acquisition of Activision Blizzard, Inc. ( )
- FTC Further Modifies 2019 Order Requiring Praxair, Inc. and Linde AG to Sell Assets in Nine Industrial Gases Product Markets ( )
- FTC Approves Final Order against JAB Consumer Partners to Protect Pet Owners from Private Equity Firm’s Rollup of Veterinary Services Clinics ( )